发明授权
US06677383B1 Hydroxylation activated prodrugs 有权
羟化活化前药

Hydroxylation activated prodrugs
摘要:
The present invention concerns enzymatic aromatic hydroxylation-activated prodrugs, particularly anti-tumor prodrugs and those which are specifically activated by the hydroxylation activity of the enzyme CYP1B1.
信息查询
0/0